Presented by The Wistar Institute in collaboration with the Society for Immunotherapy of Cancer
This conference focused on the pathological functions of myeloid-derived suppressor cells, dendritic cells, macrophages and neutrophils, and provided a forum for in-depth discussion of the most pressing issues associated with the biology and clinical application of these cells. The conference brought together scientists from academia and industry interested in the basic and translational aspects of these cells in pathological conditions, especially cancer.
With the development of novel immunotherapeutics, it has become apparent that regulatory myeloid cells play a major role in limiting the therapeutic efficacy of treatment. The specific goal of this meeting was for attendees to develop a better understanding of the mechanisms regulating the accumulation of these cells; the markers that allow for detection of these cells in patients with cancer, chronic infections and inflammation; and approaches to therapeutic targeting of these cells.
Robert A. Weinberg, PhD, from the Whitehead Institute for Biomedical Research and the Massachusetts Institute of Technology, gave the keynote presentation. Several Society for Immunotherapy of Cancer (SITC) members presented at this program, and the following SITC members served on the International Scientific Committee for the conference:
In addition to the scientific sessions, The Wistar Institute accepted abstracts for planned poster sessions. Several additional oral presentations were selected from submitted abstracts. Find more information on abstract submission here.
The Wistar Institute is an independent medical research and training institution and is an international leader in basic biomedical research. Find additional conference information here.
